橄叶提取物 (OLE) 降低了巨细胞介导的过敏炎症
Fabio Somma1, Benedetta Romano1, Daniela Claudia Maresca1
1Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|December 25, 2024
概括
橄叶提取物 (OLE) 通过抑制巨细胞降粒和释放炎症性细胞因子,有效降低过敏性炎症. 这种天然化合物调节信号传递和NF-kB激活,为巨细胞相关疾病提供了潜在的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 乳腺细胞介导反应是喘和皮肤炎等过敏性疾病的核心.
- 现有的抗胺药物面临着副作用和耐药性的挑战,需要新的治疗策略.
- 橄叶提取物 (OLE) 是一种天然产品,具有已知的抗氧化和抗瘤特性.
研究的目的:
- 为了研究OLE对人类巨细胞的抗过敏作用.
- 阐明OLE在巨细胞介导炎症中的作用背后的机制.
主要方法:
- 人类巨细胞 (HMC-1.2) 通过使用博12-米里酸和离子体A23187 (PMACI) 激活.
- 测量了OLE对胰岛素和β-hexosaminidase释放的影响.
- 分析了促炎性细胞因子 (TNF-α,IL-8,IL-6) 的基因和蛋白质表达.
- 评估了ROS的产生,线粒体质量,膜潜力和NF-kB激活.
主要成果:
- 通过调节信号传递,OLE显著降低了激活性巨细胞释放的组胺和β-hexosaminidase的释放量.
- OLE抑制了PMACI诱导的TNF-α,IL-6和IL-8的基因表达和分泌.
- 这些抗炎作用与减少的活性氧物种 (ROS) 和改变的线粒体功能有关.
- 证实了OLE的抑制作用依赖于核因子-卡帕B (NF-kB) 激活的调节.
结论:
- OLE有效地抑制瘤细胞脱粒和促炎细胞因子的释放.
- OLE通过调节信号,ROS产生,线粒体功能和NF-kB激活来起作用.
- OLE 呈现出一个有前途的治疗候选人,用于管理与巨细胞相关的过敏疾病.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:19Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
01:38Inflammation
52.5K
Overview
52.5K
02:06Allergic Reactions
27.2K
Overview
27.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:27Allergic Drug Reactions
810
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
810